China, Five Other Nations Eyed In U.S. Drug Maker Bribery Probe
This article was originally published in PharmAsia News
Executive Summary
China is among several nations mentioned in a U.S. probe of major drug companies suspected of paying bribes to officials in other countries to garner favorable treatment